alexa Hemorrhagic and thrombotic complications in bone marrow transplant recipients.
Genetics & Molecular Biology

Genetics & Molecular Biology

Journal of Stem Cell Research & Therapy

Author(s): Nadir Y, Brenner B

Abstract Share this page

Abstract Hemostatic challenges occur throughout the period of stem cell transplantation (SCT). Endothelial cells injury due to chemotherapy, growth factors, intravenous catheter, and graft-versus-host disease and profound thrombocytopenia are the major components involved in the hemostatic complications. Diffuse alveolar hemorrhage and hemorrhagic cystitis are severe complications in SCT recipients with high morbidity and mortality rate and no effective treatment. Common thrombotic manifestations include Veno-occlusive disease (VOD) and central venous lines thrombosis. More intensive conditioning regimens and mismatch donors increase the risk of hemostatic complications. Management of hemostatic and thrombotic complications is discussed including current data on the role of recombinant factor VIIa for severe hemorrhage and defibrotide for VOD. This article was published in Thromb Res and referenced in Journal of Stem Cell Research & Therapy

Relevant Expert PPTs

Relevant Speaker PPTs

Recommended Conferences

Relevant Topics

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version